Peel Hunt Reiterates “Buy” Rating for Syncona (LON:SYNC)

Syncona (LON:SYNC)‘s stock had its “buy” rating reiterated by equities research analysts at Peel Hunt in a research report issued on Tuesday,Digital Look reports. They currently have a GBX 189 price objective on the stock. Peel Hunt’s target price indicates a potential upside of 77.63% from the company’s current price.

Syncona Stock Down 0.4%

Shares of LON SYNC opened at GBX 106.40 on Tuesday. Syncona has a 52 week low of GBX 86.80 and a 52 week high of GBX 109.80. The business has a 50-day simple moving average of GBX 103.03 and a two-hundred day simple moving average of GBX 97.38. The company has a market cap of £647.12 million, a P/E ratio of -73.38 and a beta of 0.52.

Insiders Place Their Bets

In other news, insider John Roche bought 16,063 shares of the stock in a transaction on Friday, June 19th. The shares were acquired at an average cost of GBX 100 per share, for a total transaction of £16,063. Company insiders own 0.75% of the company’s stock.

Syncona Company Profile

Syncona’s purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.